These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 9264077)

  • 1. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration.
    Ushijima I; Mizuki Y; Suetsugi M; Akimoto T; Yamada M
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):709-21. PubMed ID: 9682282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of dilazep on cholinergic, dopaminergic, and purinergic systems in the rat.
    Ushijima I; Mizuki Y; Ukita T; Kaneyuki H; Inano S; Yamada M
    Pharmacol Biochem Behav; 1992 Nov; 43(3):673-6. PubMed ID: 1360158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.
    Verma A; Kulkarni SK
    Psychopharmacology (Berl); 1992; 109(4):477-83. PubMed ID: 1365866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats.
    Jones CK; Eberle EL; Shaw DB; McKinzie DL; Shannon HE
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1055-63. PubMed ID: 15574685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic methamphetamine on SCH23390- or haloperidol-induced catalepsy, and effects of coadministration of SCH23390 or haloperidol in mice.
    Mizuki Y; Ushijima I; Yamada M
    Pharmacol Biochem Behav; 1996 Feb; 53(2):437-40. PubMed ID: 8808155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
    Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
    Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of cataleptic responses induced by dopamine receptor antagonists after chronic cocaine administration in mice.
    Ushijima I; Mizuki Y; Yamada M
    Eur J Pharmacol; 1995 Oct; 285(1):55-9. PubMed ID: 8846811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.
    Glenthøj B
    Psychopharmacology (Berl); 1993; 113(2):157-66. PubMed ID: 7855176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.
    Haraguchi K; Ito K; Kotaki H; Sawada Y; Iga T
    Drug Metab Dispos; 1997 Jun; 25(6):675-84. PubMed ID: 9193868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists.
    Zhou LW; Zhang SP; Connell TA; Weiss B
    J Pharmacol Exp Ther; 1993 Feb; 264(2):824-30. PubMed ID: 8094754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity.
    Marin C; Parashos SA; Kapitzoglou-Logothetis V; Peppe A; Chase TN
    Pharmacol Biochem Behav; 1993 May; 45(1):195-200. PubMed ID: 8516358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics.
    Undie AS; Friedman E
    Psychopharmacology (Berl); 1988; 96(3):311-6. PubMed ID: 2906152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
    Braun AR; Laruelle M; Mouradian MM
    J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pertussis toxin on behavioral responses during different withdrawal periods from chronic cocaine treatment.
    Ushijima I; Mizuki Y; Kobayashi T; Aoki T; Suetsugi M; Usami K; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Nov; 24(8):1369-77. PubMed ID: 11125860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists.
    Moore NA; Blackman A; Awere S; Leander JD
    Eur J Pharmacol; 1993 Jun; 237(1):1-7. PubMed ID: 8359205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On filo- and ontogenetic development of dopaminergic regylation of wakefulness-sleep cycle in vertabrates].
    Oganesian GA; Aristakesian EA; Romanova IV; Vataev SI; Kuzik VV
    Ross Fiziol Zh Im I M Sechenova; 2012 Oct; 98(10):1213-27. PubMed ID: 23401916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
    Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
    Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the dopaminergic receptors of the rat basolateral amygdala in anxiolytic-like effects of the cholinergic system.
    Zarrindast MR; Sroushi A; Bananej M; Vousooghi N; Hamidkhaniha S
    Eur J Pharmacol; 2011 Dec; 672(1-3):106-12. PubMed ID: 21968140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.